Stay updated on Inotuzumab Ozogamicin in B-ALL Clinical Trial
Sign up to get notified when there's something new on the Inotuzumab Ozogamicin in B-ALL Clinical Trial page.

Latest updates to the Inotuzumab Ozogamicin in B-ALL Clinical Trial page
- CheckyesterdayChange DetectedThe latest history entry for NCT03959085 adds Contacts/Locations and Study Status (version 48 dated 2025-10-24). A prior entry from 2025-09-18 has been removed.SummaryDifference0.3%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference9%

- Check29 days agoChange DetectedUpdate: version bumped from v3.0.2 to v3.1.0, indicating a new release. No other content changes are indicated.SummaryDifference0.2%

- Check37 days agoChange DetectedUpdated dates and study status/contacts/locations added; an older date removed, indicating refreshed timing and contact information.SummaryDifference1.0%

- Check44 days agoChange DetectedRelease upgraded from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.SummaryDifference0.5%

- Check51 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.5%

Stay in the know with updates to Inotuzumab Ozogamicin in B-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inotuzumab Ozogamicin in B-ALL Clinical Trial page.